4 Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abrahamsen, 1993, Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age, Journal of Clinical Oncology, 11, 255, 10.1200/JCO.1993.11.2.255
Andrieu, 1990, Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease, Journal of Clinical Oncology, 8, 1148, 10.1200/JCO.1990.8.7.1148
Bajorin, 1993, Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy, Journal of the National Cancer Institute, 85, 60, 10.1093/jnci/85.1.60
Bergsagel, 1979, The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia, New England Journal of Medicine, 301, 743, 10.1056/NEJM197910043011402
Boice, 1988, Carcinogenesis: a synopsis of human experience with external exposure in medicine, Health Physics, 55, 621, 10.1097/00004032-198810000-00003
Boice, 1987, Radiation dose and leukemia risk in patients treated for cancer of the cervix, Journal of the National Cancer Institute, 79, 1295
Bokemeyer, 1993, Secondary neoplasms following treatment of malignant germ cell tumors, Journal of Clinical Oncology, 11, 1703, 10.1200/JCO.1993.11.9.1703
Bokemeyer, 1995, Treatment of testicular cancer and the development of secondary malignancies, Journal of Clinical Oncology, 13, 283, 10.1200/JCO.1995.13.1.283
Bonadonna, 1973, Secondary neoplasms in malignant lymphoma after intensive therapy, New England Journal of Medicine, 288, 1242, 10.1056/NEJM197306072882316
Boshoff, 1995, Secondary tumours following etoposide containing therapy for germ cell cancer, Annals of Oncology, 6, 35, 10.1093/oxfordjournals.annonc.a059037
Bosl, 1989, Isochromosome of chromosome 12: clinically useful marker for male germ cell tumors, Journal of the National Cancer Institute, 81, 1874, 10.1093/jnci/81.24.1874
Canellos, 1975, Second malignancies complicating Hodgkin's disease in remission, Lancet, i, 947, 10.1016/S0140-6736(75)92007-3
Chambers, 1989, Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer, Cancer, 64, 2459, 10.1002/1097-0142(19891215)64:12<2459::AID-CNCR2820641210>3.0.CO;2-T
Coleman, 1977, Hematologic neoplasia in patients treated for Hodgkin's disease, New England Journal of Medicine, 297, 1249, 10.1056/NEJM197712082972303
Coleman, 1982, Functional hyposplenia after splenic irradiation for Hodgkin's disease, Annals of Internal Medicine, 96, 44, 10.7326/0003-4819-96-1-44
Coltman, 1982, Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year follow-up, Cancer Treatment Reports, 66, 1023
Court-Brown, 1957, Leukaemia and Aplastic Anaemia in Patients Irradiated for Ankylosing Spondylitis
Curtis, 1992, Risk of leukemia after chemotherapy and radiation treatment for breast cancer, New England Journal of Medicine, 326, 1745, 10.1056/NEJM199206253262605
Curtis, 1994, Relationship of leukemia risk to radiation dose following cancer of the uterine corpus, Journal of the National Cancer Institute, 86, 1315, 10.1093/jnci/86.17.1315
Cuzick, 1987, A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis, British Journal of Cancer, 55, 523, 10.1038/bjc.1987.107
Dailey, 1980, Splenic injury caused by therapeutic irradiation, American Journal of Surgical Pathology, 5, 325, 10.1097/00000478-198106000-00002
Darrington, 1994, Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies, Journal of Clinical Oncology, 12, 2527, 10.1200/JCO.1994.12.12.2527
DeCillis, 1995, Acute myeloid leukemia (AML) in NSAPB B-25
Dietrich, 1994, M. Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?, Blood, 84, 1209, 10.1182/blood.V84.4.1209.1209
Ellis, 1993, A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias, Leukemia and Lymphoma, 11, 9, 10.3109/10428199309054725
Fenaux, 1991, Therapy related myelodysplastic syndrome and leukemia with no ‘unfavourable’ cytogenetic findings have a good response to intensive chemotherapy: a report on 15 cases, Leukemia and Lymphoma, 5, 117, 10.3109/10428199109068114
Fisher, 1985, Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience, Journal of Clinical Oncology, 3, 1630, 10.1200/JCO.1985.3.12.1640
Gomez, 1982, Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma, Cancer, 50, 2285, 10.1002/1097-0142(19821201)50:11<2285::AID-CNCR2820501111>3.0.CO;2-B
Greene, 1983, Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma, Cancer Research, 43, 1891
Greene, 1985, Carmustine as a cause of acute nonlymphocytic leukemia, New England Journal of Medicine, 313, 579, 10.1056/NEJM198508293130911
Greene, 1986, Melphalan may be a more potent leukemogen than is cyclophosphamide, Annals of Internal Medicine, 105, 360, 10.7326/0003-4819-105-3-360
1987, French registry of acute leukemia and myelodysplastic syndromes. Age distribution and hemogram analysis of the 4496 cases recorded during 1982–1983 and classified according to FAB criteria, Cancer, 60, 1385, 10.1002/1097-0142(19870915)60:6<1385::AID-CNCR2820600637>3.0.CO;2-I
Haddow, 1948, The growth-inhibitory and carcinogenic properties of 4-Aminostilbene and derivatives, Philosophical Transactions of the Royal Society, Series A, 241, 247, 10.1098/rsta.1948.0011
Hawkins, 1992, Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer, British Medical Journal, 304, 951, 10.1136/bmj.304.6832.951
Henry-Amar, 1992, Second cancer after the treatment for Hodgkin's disease: A report from the International Database on Hodgkin's Disease, Annals of Oncology, 3, S117, 10.1093/annonc/3.suppl_4.S117
Henry-Amar, 1993, Acute leukemia after the treatment of Hodgkin's disease. (review), Hematology/Oncology Clinics of North America, 7, 369, 10.1016/S0889-8588(18)30246-6
Hoppe, 1992, Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease, Leukemia, 6, 155
Kaldor, 1987, Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries, International Journal of Cancer, 39, 571, 10.1002/ijc.2910390506
Kaldor, 1988, Quantifying the carcinogenicity of antineoplastic drugs, European Journal of Cancer and Clinical Oncology, 24, 703, 10.1016/0277-5379(88)90302-1
Kaldor, 1990, Leukemia following Hodgkin's disease, New England Journal of Medicine, 322, 7, 10.1056/NEJM199001043220102
Kaldor, 1990, Leukemia following chemotherapy for ovarian cancer, New England Journal of Medicine, 322, 1, 10.1056/NEJM199001043220101
Kleinerman, 1985, Second cancer following cancer of the male genital system in Connecticut, 1935–82, National Cancer Institute Monographs, 68, 139
Kreissman, 1992, Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia, Cancer, 70, 2208, 10.1002/1097-0142(19921015)70:8<2208::AID-CNCR2820700832>3.0.CO;2-P
Kyle, 1970, Multiple myeloma and acute myelomonocytic leukemia, New England Journal of Medicine, 283, 1121, 10.1056/NEJM197011192832101
Lavey, 1990, Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas, Cancer, 66, 80, 10.1002/1097-0142(19900701)66:1<80::AID-CNCR2820660116>3.0.CO;2-9
Levine, 1992, Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure, 19, 47
Lishner, 1991, Second malignant neoplasms in patients with non Hodgkin's lymphoma, Hematological Oncology, 9, 169, 10.1002/hon.2900090308
Lorico, 1988, Increase in etoposide-induced topoisomerase II-mediated DNA breaks after cell synchronization induced by low doses of methorexate, Biochemical Pharmacology, 37, 1883, 10.1016/0006-2952(88)90494-7
Marty, 1993, Epirubicin and the risk of leukemia: not substantiated? (letter), Journal of Clinical Oncology, 11, 1431, 10.1200/JCO.1993.11.7.1431
Mauch, 1985, Reduction of fatal complications from combined modality therapy in Hodgkin's disease, Journal of Clinical Oncology, 3, 501, 10.1200/JCO.1985.3.4.501
Meadows, 1989, Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors, Medical and Pediatric Oncology, 17, 477, 10.1002/mpo.2950170525
Mendenhall, 1989, The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease, Radiotherapy and Oncology, 14, 219, 10.1016/0167-8140(89)90170-9
Michels, 1985, Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases, Blood, 65, 1364, 10.1182/blood.V65.6.1364.bloodjournal6561364
Miller, 1994, Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy, Blood, 83, 3780, 10.1182/blood.V83.12.3780.3780
Møller, 1993, Incidence of second primary cancer following testicular cancer, European Journal of Cancer, 29A, 672, 10.1016/S0959-8049(05)80344-2
Neglia, 1991, Second neoplasms after acute lymphoblastic leukemia in childhood, New England Journal of Medicine, 325, 1330, 10.1056/NEJM199111073251902
Nichols, 1990, Hematologic neoplasia associated with primary mediastinal germ-cell tumors, New England Journal of Medicine, 322, 1425, 10.1056/NEJM199005173222004
Nichols, 1993, Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols, Journal of the National Cancer Institute, 85, 36, 10.1093/jnci/85.1.36
Olsen, 1993, Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries, British Medical Journal, 307, 1030, 10.1136/bmj.307.6911.1030
Osterlind, 1985, Second cancer following cancer of the male genital system in Denmark, 1943–80, National Cancer Institute Monographs, 68, 341
Ozols, 1988, A randomized trial of standard chemotherapy vs a high-dose chemotherapy regimen in the treatment of poor prognosis non seminomatous germ cell tumours, Journal of Clinical Oncology, 6, 1031, 10.1200/JCO.1988.6.6.1031
Pedersen-Bjergaard, 1992, Radiotherapy- and chemotherapy-induced myelodysplasia and acute myeloid leukemia: a review, Leukemia Research, 16, 61, 10.1016/0145-2126(92)90102-D
Pedersen-Bjergaard, 1991, Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II, Blood, 78, 1147, 10.1182/blood.V78.4.1147.1147
Pedersen-Bjergaard, 1994, The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation, Blood, 83, 2780, 10.1182/blood.V83.10.2780.2780
Pedersen-Bjergaard, 1980, Acute nonlymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with treosulfan (=dihydroxybusulfan), Cancer, 45, 19, 10.1002/1097-0142(19800101)45:1<19::AID-CNCR2820450106>3.0.CO;2-L
Pedersen-Bjergaard, 1985, Risk of acute non-lymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents, Annals of Internal Medicine, 103, 195, 10.7326/0003-4819-103-2-195
Pedersen-Bjergaard, 1985, Acute nonlymphocytic leukemia following treatment of testicular cancer and gastric cancer with combination chemotherapy not including alkylating agents: report of two cases, America Journal of Hematology, 18, 425, 10.1002/ajh.2830180413
Pedersen-Bjergaard, 1987, Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease: Relation to age, cumulative dose of alkylating agents and time from chemotherapy, Lancet, ii, 83, 10.1016/S0140-6736(87)92744-9
Pedersen-Bjergaard, 1990, Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia, Blood, 76, 1083, 10.1182/blood.V76.6.1083.1083
Pedersen-Bjergaard, 1991, Increased risk of myelodysplasia and leukemia after etoposide, cisplatin, and bleomycin for germ-cell tumors, Lancet, 338, 359, 10.1016/0140-6736(91)90490-G
Pedersen-Bjergaard, 1992, Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epidoxorubicin and cisplatin or cyclophosphamide for breast cancer, Journal of Clinical Oncology, 9, 1444, 10.1200/JCO.1992.10.9.1444
Pedersen-Bjergaard, 1993, Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series, Leukemia, 7, 1975
Preston, 1994, Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma, and multiple myeloma. 1950–1987, Radiation Research, 137, S68, 10.2307/3578893
Pui, 1990, Myeloid neoplasia in children treated for solid tumours, Lancet, 336, 417, 10.1016/0140-6736(90)91956-B
Pui, 1991, Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia, New England Journal of Medicine, 325, 1682, 10.1056/NEJM199112123252402
Ratain, 1987, Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small cell carcinoma of the lung, Blood, 70, 1412, 10.1182/blood.V70.5.1412.1412
Redman, 1984, Leukaemia following treatment of germ cell tumours in men, Journal of Clinical Oncology, 2, 1080, 10.1200/JCO.1984.2.10.1080
Reimer, 1977, Acute leukemia after alkylating-agent therapy of ovarian cancer, New England Journal of Medicine, 297, 177, 10.1056/NEJM197707282970402
Rieche, 1984, Carcinogenicity of antineoplastic agents in man, Cancer Treatment Reviews, 11, 39, 10.1016/0305-7372(84)90016-1
Riggi, 1993, Therapy-related leukemia: what is the role of 4-epi-doxorubicin?, Journal of Clinical Oncology, 11, 1430, 10.1200/JCO.1993.11.7.1430
Rosner, 1974, Multiple myeloma terminating in acute leukemia: report of 12 cases and review of the literature, American Journal of Medicine, 57, 927, 10.1016/0002-9343(74)90171-5
Roth, 1988, Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long term follow-up, Journal of Clinical Oncology, 6, 1239, 10.1200/JCO.1988.6.8.1239
Rubin, 1991, Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy, Blood, 78, 2982, 10.1182/blood.V78.11.2982.2982
Sandoval, 1993, Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation, Journal of Clinical Oncology, 11, 1039, 10.1200/JCO.1993.11.6.1039
Schmähl, 1977
Shimkin, 1966, Bioassay of 29 alkylating chemicals by the pulmonary-tumor response in strain A mice, Journal of the National Cancer Institute, 36, 915
Sieber, 1975, Toxicity of antineoplastic agents in man, Advances in Cancer Research, 22, 57, 10.1016/S0065-230X(08)60176-1
Smith, 1994, Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks, Medical and Pediatric Oncology, 23, 86, 10.1002/mpo.2950230205
Stolley, 1982, Drugs, 304
Stone, 1994, Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma, Journal of Clinical Oncology, 12, 2535, 10.1200/JCO.1994.12.12.2535
Swerdlow, 1992, Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation, British Medical Journal, 304, 1137, 10.1136/bmj.304.6835.1137
Swerdlow, 1993, Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy, British Journal of Cancer, 68, 1006, 10.1038/bjc.1993.470
Tan, 1987, Elevated DNA-topoisomerase II activity in nitrogen mustard-resistant human cells, 84, 7671
Tester, 1984, Second malignant neoplasms complicating Hodgkin's disease. The National Cancer Institute's experience, Journal of Clinical Oncology, 2, 762, 10.1200/JCO.1984.2.7.762
Travis, 1993, Second cancers among long-term survivors of non-Hodgkin's lymphoma, Journal of the National Cancer Institute, 85, 1932, 10.1093/jnci/85.23.1932
Travis, 1994, Risk of leukemia following treatment for non-Hodgkin's lymphoma, Journal of the National Cancer Institute, 86, 1450, 10.1093/jnci/86.19.1450
Traweek, 1994, Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma, Blood, 84, 957, 10.1182/blood.V84.3.957.957
Tucker, 1993, Secondary cancers, vol 2, 2407
Tucker, 1987, Leukemia after therapy with alkylating agents for childhood cancer, Journal of the National Cancer Institute, 78, 459, 10.1093/jnci/78.3.459
Tucker, 1988, Risk of second cancers after treatment for Hodgkin's disease, New England Journal of Medicine, 318, 76, 10.1056/NEJM198801143180203
Tura, 1993, Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease, Journal of Clinical Oncology, 11, 925, 10.1200/JCO.1993.11.5.925
Upton, 1975, Physical carcinogenesis: Radiation. History and sources, vol 1, 387
Valagussa, 1995, Carcinogenic effects of cancer treatment, vol 2, 2348
Valagussa, 1994, Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer, Annals of Oncology, 5, 803, 10.1093/oxfordjournals.annonc.a059008
van der Velden, 1988, Subsequent development of acute nonlymphocytic leukemia in patients treated for Hodgkin's disease, International Journal of Cancer, 42, 252, 10.1002/ijc.2910420218
van Imhoff, 1986, Acute non-lymphocytic leukemia 5 years after treatment with cisplatin, vinblastin and bleomycin for disseminated testicular cancer, Cancer, 57, 984, 10.1002/1097-0142(19860301)57:5<984::AID-CNCR2820570518>3.0.CO;2-H
van Leeuwen, 1987, Splenectomy in Hodgkin's disease and second leukaemias (letter), Lancet, ii, 210, 10.1016/S0140-6736(87)90782-3
van Leeuwen, 1993, Second cancer risk following testicular cancer: A follow-up study of 1909 patients, Journal of Clinical Oncology, 11, 415, 10.1200/JCO.1993.11.3.415
van Leeuwen, 1994, Second cancer risk following Hodgkin's disease: a 20-year follow-up study, Journal of Clinical Oncology, 12, 312, 10.1200/JCO.1994.12.2.312
van Leeuwen, 1994, Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, numbers of episodes of chemotherapy and bone marrow damage, Journal of Clinical Oncology, 12, 1063, 10.1200/JCO.1994.12.5.1063
Winick, 1993, Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide, Journal of Clinical Oncology, 11, 209, 10.1200/JCO.1993.11.2.209